C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 275/42 (2006.01) A61K 31/16 (2006.01) A61K 31/167 (2006.01) A61K 31/17 (2006.01) C07C 237/22 (2006.01)
Patent
CA 2318639
Compounds of formula (I) and their pharmaceutically acceptable salts are VLA-4 antagonists. They are useful in inhibiting cell adhesion and in the therapeutic or prophylactic treatment of inflammatory and autoimmune diseases, particularly inflammatory airways diseases. They are particularly useful in reducing post-surgical inflammation, especially that resulting from transplant surgery.
Les composés correspondant à la formule (I) ainsi que leurs sels acceptables du point de vue pharmaceutique sont des antagonistes du VLA-4. Ils inhibent efficacement l'adhésion cellulaires et se révèlent comme des plus utiles en matière de traitement ou de prophylaxie de maladies inflammatoires ou auto-immunes, notamment des maladies inflammatoires des voies respiratoires. Ils s'avèrent particulièrement efficaces s'agissant d'atténuer une inflammation post-chirurgicale, résultant notamment d'une greffe.
von Matt Peter Josef
Wattanasin Sompong
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Vla-4 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vla-4 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vla-4 antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1891047